Article
HC Wainwright & Co. Downgrades Aardvark Therapeutics to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Aardvark Therapeutics (NASDAQ:AARD) from Buy to Neutral.
Comments
- No comments yet. Be the first to comment!